US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

36.95

-0.9597-2.53%

Post-market: 36.950.00000.00%16:10 EDT

Volume:799

Turnover:29.62K

Market Cap:2.77M

PE:- -

High:37.04

Open:37.04

Low:36.95

Close:37.91

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.71

T/O Rate:1.07%

Dividend:0.76

Dividend Rate:2.07%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

US Drugmakers Turn to China for Licensing Deals

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

EBR Systems advances FDA approval process for new WiSE manufacturing site

Regeneron (REGN) Receives a Hold from Bernstein

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

Dow's 500-Point Rally Highlighted by Gains in Shares of Microsoft, Sherwin-Williams Co.

US FDA Approves Mirum's Drug for Rare Bone Disorder

Regeneron Steps Into Obesity Drug Race With New Phase 1 Study

Argenx Advances Empasiprubart Into Phase 2 for Guillain-Barré: What Investors Should Watch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/TBXU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":36.95,"timestamp":1790971200000,"preClose":37.9097,"halted":0,"volume":799,"hourTrading":{"tag":"盘后","latestPrice":36.95,"preClose":36.95,"latestTime":"16:10 EDT","volume":7,"amount":258.65,"timestamp":1790971805107,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.025315420591563585,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Market Closed","change":-0.9597,"latestTime":"10-02 16:00:00 EDT","open":37.04,"high":37.04,"low":36.95,"amount":29615,"amplitude":0.002374,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":37.9097,"sharesOutstanding":100001,"nav":37.787,"aum":2834038.05,"dividendRate":0.020691,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.28,"preClose":37.9097,"latestTime":"08:40 EDT","volume":3,"amount":117.84,"timestamp":1790944836091,"change":1.3703,"changeRate":0.036146,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.95,"preClose":36.95,"latestTime":"16:10 EDT","volume":7,"amount":258.65,"timestamp":1790971805107,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7050829571574564},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7050829571574564,"shares":75001,"dividePrice":0.76452,"high":37.04,"amplitude":0.002374,"preClose":37.9097,"low":36.95,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":36.95,"eps":0,"divideRate":0.020691,"volume":799,"delay":0,"ttmEps":0,"open":37.04,"prevYearClose":31.065,"prevWeekClose":40.5306,"prevMonthClose":39.9,"prevQuarterClose":39.9,"fiveDayClose":40.5306,"twentyDayClose":45.76,"sixtyDayClose":33.8804},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-09-22","symbol":"TBXU","amount":0.14204,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-22","defaultRemindTime":1790083800000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-22","currency":"USD","dateTimestamp":1790049600000,"payDate":"2026-09-29"},{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"},{"executeDate":"2026-09-22","recordDate":"2026-09-22","paymentDate":"2026-09-29","value":0.14204,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671329926","title":"SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671329926","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671329926?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:23","pubTimestamp":1790666588,"startTime":"0","endTime":"0","summary":"SoftOx names Dr. Bruce Montgomery to chair Clinical Advisory BoardSoftOx appointed Dr. A. Bruce Montgomery to establish and chair its Clinical Advisory Board ahead of a planned Phase 2b SIS study.Boar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLbDg5Mx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","GILD","LU1934455277.USD","BK4568","IE0002270589.USD","LU1066051498.USD","BBH","BIB","LU2357627491.SGD","LU0823416689.USD","SG9999015986.USD","BK4578","IE00BZ1G4Q59.USD","LU1571399168.USD","LU2089984988.USD","SG9999015978.USD","TMED","LU0965509010.AUD","MEDI","LU1934455194.USD","BK4588","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1674673428.USD","BK4585","BK4583","LU1839511570.USD","LU1057294990.SGD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU0965509101.SGD","LU1934455863.HKD","LU0289739699.SGD","IBBQ","LU0234570918.USD","IE00B19Z3B42.SGD","BK4566","BK4139","BK4550","IE00BSNM7G36.USD","IE00B3T34201.USD","LU0882574055.USD","LU0965509283.SGD","LU1066053197.SGD","LU2112291526.USD","LU0859254822.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","TBXU","BK4596","IEIH","BK4559","MRNY","BK4584","LU2324357040.USD","TEVA","PINK","GDOC","BK4585","XLVX","BK4588","BK4566","SYNB","NVIB","RSPH","BBP","LFSC","LABU","BK4557","BK4007","MRNX","BMED","TECB","FRTY","LU1983299246.USD","MEDI","IBB","IDNA","PSCH","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257160","title":"Teva Wins US FDA Approval for Xgeva Biosimilar Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257160?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625646,"startTime":"0","endTime":"0","summary":"Teva wins US FDA approval for Xgeva biosimilar DEGEVMATeva won FDA clearance for DEGEVMA (denosumab-adet), a biosimilar to Amgen’s Xgeva.Label covers Xgeva’s full uses, including prevention of bone co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4w4Bbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","BK4533","IE00B4R5TH58.HKD","IBB","IE00B64PRP62.GBP","LU1061106388.HKD","BK4566","LU1571399168.USD","BK4599","LU0320765992.SGD","IE00BN0W2V16.EUR","BCDF","NDAQ","IE00BN0W2T93.GBP","TBXU","IE00BKPKM429.USD","LU0889565916.HKD","LU2112291526.USD","IE0002141913.USD","PBE","BK4534","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4585","IE0009355771.USD","LU1983299246.USD","BK4139","IE00BQXX3F31.USD","LU1057294990.SGD","SG9999014021.USD","IE00BQXX3D17.EUR","AMGN","SG9999014013.SGD","PJP","IE00BN0W2W23.USD","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","LU0314104364.USD","LU2210149790.SGD","BK4112","LU0058720904.USD","BBH","BK4588","LU2242646821.SGD","SG9999014039.USD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252933","title":"Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620623,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix tumbles on rival Kodiak's trial win, analyst calls selloff overdone** Shares of Ocular TherapeutixOCUL.Ofall 18.8% to $7.84 in afternoon trading** Kodiak Sciences'KOD.Oexperime","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K1CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434740.USD","BK4007","IBBQ","REGN","OCUL","LU0882574055.USD","BK4585","LU0058720904.USD","LU1917777945.USD","LU2362541273.HKD","LU0053666078.USD","KOD","LU0823416689.USD","BBH","BK4505","LU1974910355.USD","TBXU","BK4588","LU0889565916.HKD","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","LU0109394709.USD","LU0114720955.EUR","LU2362541513.USD","LU2237438978.USD","LU0289739699.SGD","LU0823434583.USD","LU2023250504.SGD","LU2089984988.USD","LU2468319806.SGD","IBB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671259773","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671259773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671259773?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:00","pubTimestamp":1790611227,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN) and Kodiak Sciences (KOD). Regeneron (REGN) Citi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1917777945.USD","LU0889565916.HKD","LU2362541273.HKD","BK4139","LU2237438978.USD","LU2362540622.SGD","LU0823416689.USD","LU2468319806.SGD","BK4585","HCSG","LU2362541513.USD","LU0289739699.SGD","LABU","LU0128526141.USD","LU0882574055.USD","BK4137","LU2106854487.HKD","LU2023250504.SGD","LU0058720904.USD","XBI","KOD","BK4588","XLV","LU1974910355.USD","LU0823434740.USD","BK4505","LU0320765992.SGD","LU2089984988.USD","BBH","IBBQ","LU0053666078.USD","LU0029874061.USD","LU0823434583.USD","LU0109394709.USD","BK4581","IBB","LU0114720955.EUR","TBXU","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670564812","title":"Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670564812","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670564812?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:23","pubTimestamp":1790609027,"startTime":"0","endTime":"0","summary":"UPDATE 1-Mirum's liver infection drug lowers virus levels in late-stage studySept 28 (Reuters)-Mirum PharmaceuticalsMIRM.Oon Monday said its experimental hepatitis drug reduced levels of the virus in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K14L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU1023059063.AUD","LU1430594728.SGD","LU0058720904.USD","LU1585245621.USD","LU2468319806.SGD","IBBQ","LU2089984988.USD","TMED","GILD","MEDI","BIB","LU1057294990.SGD","LU0861579265.USD","LU0965509283.SGD","LU0234570918.USD","LU1674673428.USD","LU2324357040.USD","LU1066053197.SGD","BK4585","LU2087621335.USD","SG9999015986.USD","LU0965509101.SGD","BK4532","IE00BSNM7G36.USD","LU1778281490.HKD","LU0289739699.SGD","MIRM","BBH","LU2357627491.SGD","LU0122379950.USD","TBXU","LU0859254822.USD","IBB","IE00B19Z3581.USD","IE0002270589.USD","IE00B3T34201.USD","LU0889565916.HKD","LU2112291526.USD","BK4139","LU1839511570.USD","LU1934455863.HKD","LU1066051498.USD","IE00BKVL7J92.USD","LU0882574055.USD","BK4588","LU1934455194.USD","BK4566","SG9999015952.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670620256","title":"Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670620256","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670620256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:11","pubTimestamp":1790608260,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences more than doubled Monday after two experimental eye drugs succeeded in a late-stage trial, positioning the biopharmaceutical company to get its first product to market.Kodiak","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","OTLK","KOD","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU0889565916.HKD","LU2362541273.HKD","BBH","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU0882574055.USD","LU1974910355.USD","LU2089984988.USD","LU2106854487.HKD","BK4505","TBXU","IBB","LU2362541513.USD","IBBQ","LU0823416689.USD","BK4588","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU0109394709.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256598","title":"Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256598","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256598?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:00","pubTimestamp":1790607600,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen’s latest Sjögren’s trial success adds to its pipeline, while Repatha growth and MariTide trials shape the AMGN stock outlook for 2026.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262189733-stocks-amgen-stock-forecast-sjogrens-trial-maritide-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0310800379.SGD","LU2242652126.USD","TBXU","PBE","LU2468319806.SGD","IE0002141913.USD","IBB","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","LU2236285917.USD","BK4581","BK4588","LU2112291526.USD","LU2237443895.HKD","BK4566","AZNH","BBH","LU0029864427.USD","LU2237443978.SGD","LU2456880835.USD","IE0009355771.USD","IE00B3T34201.USD","IE00BJJMRZ35.SGD","BK4534","LU0109394709.USD","LU0889565916.HKD","LU2237443549.SGD","BK4007","LU1829250122.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","AMGN","LU0708994859.HKD","LU0432979614.USD","PJP","LU1571399168.USD","LU0122379950.USD","LU2237443622.USD","IBBQ","IE00B4R5TH58.HKD","AZN","LU1057294990.SGD","LU2237443382.USD","SG9999001440.SGD","LU2237443465.HKD","IE00BJT1NW94.SGD","BIB","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655073.USD","IE00B4R5TH58.HKD","MEDX","LU2750360641.GBP","LU1188198961.HKD","IE000M9KFDE8.USD","LU2023250330.USD","LU0965509010.AUD","IE00BDGV0183.EUR","CANC","LU0466842654.USD","LU1988902786.USD","IE0000B7K699.USD","SG9999015978.USD","IE00BVYPNW00.USD","BK4007","BK4568","LU2125909247.SGD","LU1057294990.SGD","LU1923622614.USD","JDOC","LU1116320737.USD","LU1894683264.USD","LU2462591350.SGD","LU0823434740.USD","LU2063271972.USD","LU2750360997.AUD","IE00BN29S564.USD","LU1003077747.HKD","LU1699723380.USD","LU0097036916.USD","LU0289961442.SGD","GLAM","LU0098860793.USD","BBH","LU2361045086.USD","LU0949170772.SGD","IE00BLSP4239.USD","LU0124676726.USD","BK4139","LU1989772923.USD","ELIL","LU2362541513.USD","LU0237698245.USD","BK4599","LU0683600562.USD","LU1839511570.USD","LU2456880835.USD","LU1670711123.USD","LU0320765646.SGD","LU0868494617.USD","LU1236620834.HKD","LU2471134796.USD","LU1868836757.USD","LU2087625088.SGD","BK4559","LU1116320901.HKD","LU2097828557.USD","LU0455707207.USD","LU2265009873.SGD","LU2896262040.SGD","IE00BFSS8Q28.SGD","LU2756315664.SGD","IE0001KFT4U8.USD","LU1280957306.USD","LU2462157665.USD","LU0053666078.USD","IE0004445015.USD","LU0795875169.SGD","LU1917777945.USD","LU0096364046.USD","LU0471298694.HKD","LU0385154629.USD","MEDI","LU0070302665.USD","LU0786609619.USD","LU2213496289.HKD","LU1691799644.USD","LU1061106388.HKD","LU0354030438.USD","LU1670627923.USD","LU1883839398.USD","MHIP","IE00B42XCP33.USD","LU1093756325.SGD","LU0326950275.SGD","LU2488822045.USD","LU1974910355.USD","LU0211331839.USD","LU0289739343.SGD","LU0553294199.USD","SG9999014880.SGD","IE000BZT7R73.USD","LU0823434583.USD","SG9999015986.USD","HK0000165453.HKD","LU2360106947.USD","ILDR","IHE","LU0122379950.USD","LU2129689514.USD","IE00B1XK9C88.USD","LU2023250843.SGD","LU1069344957.HKD","LU2271345857.HKD","LU2746668974.SGD","IE00BFSS7M15.SGD","LU0208291251.USD","LU0029864427.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","SG9999018857.SGD","IE00B1BXHZ80.USD","BK4588","SG9999014567.USD","LU0417517546.SGD","LU1983299246.USD","SG9999015945.SGD","VHT","LU0345770308.USD","LU2357627491.SGD","SG9999014898.SGD","SGXZ81514606.USD","LU0316494557.USD","LU0726765562.USD","BK4581","LLYZ","LU0471298777.SGD","IBB","LU0114720955.EUR","LU1732800096.USD","LU1934455863.HKD","LU2242644610.SGD","LU2264538146.SGD","LLYX","LU1831875114.USD","LU0320765489.SGD","LU2168564222.USD","LU2361044949.HKD","LU2237443382.USD","LU1941712264.USD","LU1064131342.USD","BK4550","LU0985481810.HKD","LU0061475181.USD","LU1894683348.USD","LU1267930490.SGD","LU0795875086.SGD","PFE","LU0985320562.USD","LU0069063385.USD","SG9999011175.SGD","LU1236620750.USD","LU0310800379.SGD","LU1066053197.SGD","LU0106261372.USD","LU0238689110.USD","LU0545039389.USD","IE00BGHQF631.EUR","LU0321505868.SGD","LU1720051017.SGD","LU0820562030.AUD","LU0128525929.USD","IE0004445239.USD","LU1430594728.SGD","LU2125154935.USD","FHLC","LU0912757837.SGD","BK4516","LU2111349929.HKD","LU2129689431.USD","LU2168564495.EUR","IE0009355771.USD","IE000MB6IJN5.SGD","LU2023251221.USD","LU0265550946.USD","LU0320765992.SGD","LU2360032135.SGD","SG9999014914.USD","CURE","LU1037948897.HKD","LU0661504455.SGD","SG9999001176.USD","LU0234572021.USD","LU0174119429.USD","LU0244354667.USD","SG9999015358.SGD","LU0823416689.USD","LU1941712348.USD","LU1969619763.USD","IE000F7OJYX1.SGD","IE00B7KXQ091.USD","LU1551013342.USD","LU0072461881.USD","LU0225771236.USD","LU1989772840.SGD","LU0820561818.USD","HRTS","LU0456855351.SGD","LU1814569148.SGD","LU1718418525.SGD","LU2237443549.SGD","XLV","LU0133085943.USD","BK1583","LU0130517989.USD","GB00BDT5M118.USD","LU2491049909.HKD","01801","BK1589","LU2108987350.USD","LU2237438978.USD","LU2089284900.SGD","LU0859254822.USD","GDOC","LU2461242641.AUD","LU0289739699.SGD","LU0203347892.USD","IE00B3PB1722.GBP","LU0672654240.SGD","LU1804176565.USD","LU0306807586.USD","IE00B775H168.HKD","LU1496350502.SGD","LU1571399168.USD","PJP","SG9999015341.SGD","LU2097828474.EUR","LU0158827781.USD","LU0648001328.SGD","BK4532","LU0109394709.USD","BK4566","LU2491050071.SGD","LU0198837287.USD","LU2168564065.EUR","LU2097828631.EUR","IE00BJJMRX11.SGD","LU2361044865.SGD","SGXZ57979304.SGD","LU1670710661.SGD","IE00BSNM7G36.USD","SG9999015952.SGD","LU2087621335.USD","LU2106854487.HKD","IE00B2B36J28.USD","LU0256863902.USD","LU2471134523.USD","LU0942090050.USD","LU1868836591.USD","LU1929549753.HKD","IE00BK4W5M84.HKD","SGXZ51526630.SGD","LU0861579265.USD","LU2237443465.HKD","THNR","LU0708994859.HKD","PPH","LU0353189680.USD","LU1066051225.USD","IE00BJJMRY28.SGD","LU0354030511.USD","LU0965509101.SGD","LU1023059063.AUD","LU2471134879.HKD","IE0002141913.USD","LU1267930573.SGD","SG9999002224.SGD","LU0738911758.USD","KURE","LU2552382058.USD","IE00B19Z3B42.SGD","SG9999014542.SGD","LU1127390331.HKD","LU0094547139.USD","LU2237443622.USD","LU2746668461.USD","ELIS","LU0323591593.USD","SG9999003800.SGD","LU1934455194.USD","SG9999001440.SGD","IBBQ","LU2756315318.SGD","LU2552382215.SGD","IE00B3T34201.USD","LU2129689605.HKD","LU1868836914.USD","LU0472753341.HKD","LU0203201768.USD","LU0256863811.USD","LU1629891620.HKD","LU0109391861.USD","SG9999013999.USD","LU0158827948.USD","LU2242646821.SGD","LU0058720904.USD","IE00BBT3K403.USD","LU0057025933.USD","LU2242652126.USD","IE00BFXG1179.USD","LU1066051498.USD","LU0130102774.USD","LU1585245621.USD","LU1366192091.USD","LU0203202063.USD","LU0511384066.AUD","LU0868494708.USD","MRK","IE00BJT1NW94.SGD","IE00BK4W5L77.USD","IE00BVYPNV92.GBP","LU1267930730.SGD","LU1244550221.USD","LU2468319806.SGD","LU1548497426.USD","LU0882574055.USD","IE00BJLML261.HKD","LU2112291526.USD","LU1496350171.SGD","IE00BKPKM429.USD","LU0211327993.USD","LU0079474960.USD","LU2347655156.SGD","LU0210536198.USD","LU2028103732.USD","LU1261432733.SGD","IE00B19Z3581.USD","AGNG","LU1244550577.SGD","LU0211328371.USD","LLY","LU0320765059.SGD","BK4534","LU0889565916.HKD","LU2362541273.HKD","LU0463099449.HKD","LU1623119135.USD","IE00BLSP4452.SGD","LLII","LU0820561909.HKD","BMY","LU2328871848.SGD","LU0708995401.HKD","LU1074936037.SGD","LU0203345920.USD","IYH","LU0943347566.SGD","LU1232071149.USD","LU2596442595.SGD","SG9999001176.SGD","TMED","IE00B4JS1V06.HKD","IE000WAW04H5.SGD","LU1989771016.USD","LU2552382132.HKD","ABBV","IE00BKDWB100.SGD","LU0882574139.USD","WDNA","LU2097828714.EUR","LU2471134952.CNY","LU1066051811.HKD","LU1868837136.USD","SG9999014906.USD","SG9999017495.SGD","LU2417539215.USD","BK4533","LU1670710588.SGD","LU1093756168.USD","LU1670628061.USD","BK1161","LU1201861249.SGD","LU1035773651.USD","OZEM","IE00BFTCPJ56.SGD","LU0310799852.SGD","LU0964807845.USD","LU0432979614.USD","IE00BWXC8680.SGD","SG9999002232.USD","LU1868837300.USD","SG9999014559.SGD","LU0225283273.USD","LU2491050154.USD","LU0162691827.USD","LU0225284248.USD","LU1291159041.SGD","LU1551013425.SGD","LU2357305700.SGD","LU1069347547.HKD","LU0149534421.HKD","LU0640476718.USD","LU0395794307.EUR","LU1162221912.USD","TRUH","LU0502904849.HKD","LU0607220059.USD","LU2089984988.USD","LU1244550494.USD","LU2168564149.EUR","IXJ","LU1035775433.USD","LU0689472784.USD","LU0965509283.SGD","LU2237443895.HKD","REGN","BMED","LU2236285917.USD","LU2237443978.SGD","SG9999018865.SGD","LU0306806265.USD","LU2133065610.SGD","LU2125154778.USD","LU1037948541.HKD","LU1712237335.SGD","BK4592","IE000SO60NU8.SGD","LU0353189763.USD","LU1732799900.SGD","LU2125909593.SGD","SG9999014575.USD","LU1979441026.SGD","LU2433249047.HKD","RXL","LU0234570918.USD","LU2168563687.JPY","LU1323610961.USD","LU0267386448.USD","LU1032466523.USD","BK4585","LU0980610538.SGD","LU0170899867.USD","LU0266013472.USD","LU0006306889.USD","LU2362540622.SGD","LU2324357040.USD","LU0965508806.USD","LU0787776722.HKD","IE00BN8TJ469.HKD","LU2602419157.SGD","LU0477156953.USD","SGXZ31699556.SGD","FTXH","LU0321505439.SGD","LU2023250504.SGD","LU2211815571.USD","LU1720051108.HKD","IE0005OL40V9.USD","LU0345770993.USD","LU1670711040.USD","LU2097828805.USD","LU1934455277.USD","PAWZ","LU0265550359.USD","SGXZ99366536.SGD","LU1145028129.USD","LU0689626769.HKD","LU2089283258.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2087621335.USD","LU1066053197.SGD","MEDI","SG9999015952.SGD","LU1839511570.USD","LU0965509283.SGD","TBXU","TMED","IE00BKPKM429.USD","SG9999014021.USD","LU2468319806.SGD","LU2210150020.SGD","BMED","LU1066051498.USD","SG9999014013.SGD","IBBQ","LU1934455277.USD","IE00B3QW5Z07.USD","BCDF","LU0965509101.SGD","LU0823416689.USD","LU1037948897.HKD","IE00BN0W2V16.EUR","BK4568","IE00B3T34201.USD","IE00BQXX3C00.GBP","LU0859254822.USD","LU0861579265.USD","BK4583","LU1934455863.HKD","BK4566","LU1571399168.USD","BIB","GILD","LU0234570918.USD","IE00B19Z3581.USD","NDAQ","BK4532","IE00BN0W2W23.USD","LU1061106388.HKD","IBB","LU2112291526.USD","BBH","LU2210149790.SGD","SG9999015978.USD","XLO","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239992","title":"Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239992","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239992?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592624,"startTime":"0","endTime":"0","summary":"BUZZ-Kodiak Sciences rises after eye-disease drugs meet trial goals** Shares of drug developer Kodiak SciencesKOD.Orise 43.9% to $46.56 premarket** Co says its experimental drugs Zenkuda and tabirafusp-ted met the main goals of a late-stage trial in patients with wet age-related macular degeneration** Both drugs achieved vision gains at one year that were not inferior to aflibercept, the comparison treatment** Wet age-related macular degeneration causes abnormal blood vessels to leak beneath the retina and can lead to loss of central vision** About 54% of Zenkuda patients reached a six-month dosing interval, potentially reducing the number of eye injections needed** Both drugs showed safety broadly consistent with aflibercept; Kodiak plans further analyses to identify which patients may benefit most from tabirafusp-ted** Co plans to seek US approval for Zenkuda in Q4 2026, using results from five successful late-stage studies across three retinal diseases** KOD up 15.7% YTD, as of last","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU2468319806.SGD","LU0823416689.USD","LU0823434583.USD","BK4505","BK4585","LU1917777945.USD","LU0823434740.USD","LU2023250504.SGD","IBB","LU0320765992.SGD","LU2362540622.SGD","LU0889565916.HKD","LU0882574055.USD","LU2089984988.USD","LU0053666078.USD","LU0114720955.EUR","KOD","LU1974910355.USD","LU0058720904.USD","BK4588","TBXU","LU0109394709.USD","BBH","LU2106854487.HKD","LU0289739699.SGD","LU2362541273.HKD","REGN","LU2237438978.USD","BK4139","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236928","title":"Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590220,"startTime":"0","endTime":"0","summary":"With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. FDA approval of Ziihera for first-line HER2-positive advanc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBPH","BMED","MRNX","TECB","MEDI","GDOC","GNMX","LABU","LFSC","IYH","MRNY","BK4007","BK4588","NVIB","FRTY","IDNA","XLVX","BBP","PSCH","IEIH","SYNB","RSPH","PINK","IBB","BK4585","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670808280","title":"Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670808280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670808280?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:33","pubTimestamp":1790584380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.3% to 5.50 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.This was the stock's fifth consecutive day of losses.Sino Biopharmaceutical Ltd. closed 36% short of its 52-week high of HK$8.54, which the company reached Oct. 8.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 0.6% and Amgen Inc. remained unchanged.Trading volume totaled 57.5 million shares, compared to the 50-day average of 82.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91335","LU2468319806.SGD","HK0000165453.HKD","BK1521","IBBQ","BK1191","IE0009355771.USD","LU1023059063.AUD","IE00BZ08YS42.EUR","LU2242646821.SGD","IE00BZ08YR35.GBP","PBE","IE00BJT1NW94.SGD","IBB","LU1061106388.HKD","SG9999001440.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4585","BK4139","LU1571399168.USD","BK4534","LU2089984988.USD","LU1057294990.SGD","LU0868494617.USD","LU0320765992.SGD","LU0058720904.USD","BK4581","BK4599","LU0889565916.HKD","IE00BZ08YT58.USD","IE00B2B36J28.USD","LU1983299246.USD","LU2112291526.USD","LU2242652126.USD","BK1515","LU0122379950.USD","IE00BFTCPJ56.SGD","BK1589","PJP","IE00B4R5TH58.HKD","BK4588","LU0289739699.SGD","TBXU","BIB","BBH","AMGN","01177","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","EES","PSCH","FRTY","GDOC","IDNA","MRNX","BMED","IYH","XLVX","BK4588","LABU","BBP","TECB","GNMX","TBXU","SYNB","NVIB","IBB","LFSC","IEIH","BK4585","MRNY","RSPH","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471175","title":"Regeneron (REGN) Receives a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471175?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:55","pubTimestamp":1790427321,"startTime":"0","endTime":"0","summary":"Bernstein analyst Eve Burstein maintained a Hold rating on Regeneron yesterday and set a price target of $756.00. The company’s shares closed yeste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1974910355.USD","LU2023250504.SGD","LU1917777945.USD","LU0114720955.EUR","REGN","LU0320765992.SGD","LU2362541273.HKD","LU2468319806.SGD","BBH","LU2362540622.SGD","LU0109394709.USD","LU2106854487.HKD","LU2362541513.USD","LU2089984988.USD","LU0289739699.SGD","LU0823416689.USD","LU0882574055.USD","LU2237438978.USD","BK4585","LU0053666078.USD","IBB","BK4139","LU0889565916.HKD","TBXU","BK4588","LU0058720904.USD","LU0823434740.USD","IBBQ","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471177","title":"Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471177?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:40","pubTimestamp":1790426416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A) and Regeneron (REGN) with bullish sentim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-agilent-a-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-agilent-a-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0347712357.USD","LU0889565916.HKD","LU2362541273.HKD","LU0823434583.USD","LU0320765992.SGD","LU2413666426.HKD","LU0114720955.EUR","LU2089984988.USD","BBH","LU2023250504.SGD","LU0029874061.USD","BK4137","IE00BN0W2V16.EUR","LU2229751404.USD","XLV","IBB","BK4585","LU1974910355.USD","A","LU0058720904.USD","LU0823416689.USD","LU2092937221.SGD","BK4588","BK4581","HCSG","LU0289739699.SGD","XBI","LU1917777945.USD","LU1543694498.USD","LU2362541513.USD","LU0128526141.USD","LU0109394709.USD","LU2089279066.USD","LU2362540622.SGD","LU2468319806.SGD","BK4139","BK4121","LU2041044095.USD","LU2413666699.HKD","LU0823434740.USD","REGN","IE00BN0W2W23.USD","LABU","TBXU","LU1165135440.EUR","IBBQ","LU0053666078.USD","LU2106854487.HKD","LU2237438978.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421733","title":"Dow's 500-Point Rally Highlighted by Gains in Shares of Microsoft, Sherwin-Williams Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421733","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421733?lang=en_us&edition=fundamental","pubTime":"2026-09-26 03:45","pubTimestamp":1790365500,"startTime":"0","endTime":"0","summary":"DJ Dow's 500-Point Rally Highlighted By Gains In Shares Of Microsoft, Sherwin-Williams Co.This article was automatically generated by MarketWatch using technology from Automated Insights.The Dow Jones Industrial Average is climbing Friday afternoon with shares of Microsoft and Sherwin-Williams Co. delivering the strongest returns for the index.Shares of Microsoft  and Sherwin-Williams Co.  have contributed around a third of the index's intraday rally, as the Dow  was most recently trading 500 points  higher.Microsoft's shares are up $18.53  while those of Sherwin-Williams Co. are up $9.41 , combining for a roughly 166-point boost for the Dow.Other components contributing significantly to the gain include Amgen , Caterpillar , and Apple .A $1 move in any one of the 30 components of the benchmark results in a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled September 25, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU1868837136.USD","IE000M9KFDE8.USD","LU3102509885.SGD","LU0056508442.USD","LU0345768153.USD","LU0316494557.USD","LU1868836757.USD","LU2404859741.USD","LU0053666078.USD","LU0494093205.USD","LU2347655073.USD","IE00BWXC8680.SGD","HK0000914686.HKD","LU0058720904.USD","LU0347712357.USD","LU1732799900.SGD","LU2028103732.USD","IE00BQXX3F31.USD","LU2361044865.SGD","LU1261432733.SGD","LU2954938101.SGD","IE0004086264.USD","LU2471134523.USD","LU1791710400.SGD","LU0203201768.USD","LU0265550359.USD","MSFW","LU0784384876.USD","LU1069347547.HKD","LU2433249047.HKD","LU0323591593.USD","LU1645745479.HKD","LU1778281490.HKD","LU2357627491.SGD","LU0109394709.USD","MADE","EXI","LU0210533765.USD","LU1988902786.USD","LU0175139822.USD","GB00B4QBRK32.GBP","LU2237438978.USD","IE00BYQQ9H92.USD","LU1697837992.HKD","IE00BBT3K403.USD","LU1059921491.USD","LU2089283258.USD","LU1935042991.SGD","LU0912757837.SGD","LU0444973449.USD","LU2125154778.USD","LU2756315318.SGD","LU0898699433.AUD","LU1066051225.USD","LU2054465674.USD","LU0106261372.USD","MSFY","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0708995401.HKD","LU0154236417.USD","LU1989772840.SGD","IE00B5TLWC47.USD","LU0061475181.USD","LU2420271590.USD","LU1934455863.HKD","LU1670711123.USD","LU2362541513.USD","LU1582986359.USD","IE0004091025.USD","LU2236285917.USD","LU2286300806.USD","LU0345768740.USD","LU1316542783.SGD","LU2417539215.USD","CMAG","LU0081259029.USD","LU1670710588.SGD","LU0426417589.USD","LU2250418816.HKD","IE00BQXX3C00.GBP","LU0320765059.SGD","MSFT","SGXZ81514606.USD","SG9999015945.SGD","LU0345774631.USD","LU2999663052.SGD","SGXZ99366536.SGD","LU0417517546.SGD","LU1235295455.SGD","LU1989772923.USD","LU0265550946.USD","LU2210149790.SGD","LU0426412945.USD","LU0708994859.HKD","LU0276348264.USD","LU1064131342.USD","LU1228905037.USD","IE000BZT7R73.USD","LU0158827948.USD","IE0034235295.USD","LU0267386448.USD","IE00B3S45H60.SGD","LU0642271901.SGD","LU0109391861.USD","LU2764263203.CNY","IE00BDRTCR15.USD","PJP","LU0871640123.AUD","LU0079474960.USD","LU2506951875.HKD","LU1043141396.HKD","TTXU","LU2506951958.HKD","LU2456880835.USD","LU1917777945.USD","IE00B3SWFQ91.USD","IE00B4JS1V06.HKD","LU0942090050.USD","LU0061474960.USD","LU2213496289.HKD","BK4587","LU2275660780.HKD","LU2361045086.USD","SNPE","LU2112291526.USD","LU2458330243.SGD","04332","LU0256863811.USD","LU0994945656.USD","LU2108987350.USD","IE00B5949003.HKD","SG9999002224.SGD","LU0210536198.USD","LU1066053197.SGD","GAMR","LU0861579265.USD","LU1548497426.USD","LU2168564222.USD","BK4527","BIB","LU2092937148.SGD","IE00BJTD4N35.SGD","LU1116320901.HKD","LU1188199696.SGD","LU0122379950.USD","LU2102340556.USD","MSFL","LU2720916845.USD","LU2413666426.HKD","SG9999001424.SGD","SG9999002232.USD","LU0158827781.USD","LU1791710582.SGD","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","LU0095938881.EUR","LU1803068623.USD","LU0784385170.HKD","IE00B19Z8W00.USD","LU0823434740.USD","LU1934455194.USD","HK0000819398.USD","LU0096362180.USD","SGXZ31699556.SGD","SG9999001440.SGD","LU0187121727.USD","LU0726765562.USD","LU2095319765.USD","LU2362540622.SGD","LU2552382132.HKD","LU1093756168.USD","LU0127658192.USD","LU1674673428.USD","BK4538","CNEQ","LU0170899867.USD","LU1732800096.USD","LU0345774391.USD","BK4612","LU2097344431.USD","LU1823568750.SGD","LU0345770993.USD","LU0070302665.USD","LU0345769128.USD","HK0000914660.USD","LU1934455277.USD","LU1868836914.USD","LU1691799644.USD","LU2210150020.SGD","LU1366192091.USD","LU1642822529.SGD","SG9999015978.USD","BK4109","LU0077335932.USD","IE00B4R5TH58.HKD","SG9999014542.SGD","LU0096364046.USD","LU0957791311.USD","LU0859254822.USD","LU1035775433.USD","LU1301847155.USD","LU1236620834.HKD","LU0057025933.USD","LU0308772762.SGD","LU0211331839.USD","LU0795875169.SGD","LU0882574139.USD","BK4532","LU0757359368.USD","LU1032466523.USD","IE00BKDWB100.SGD","LU2168563687.JPY","LU1037948541.HKD","LU2360032135.SGD","LU1551013425.SGD","LU2746668461.USD","IE000WAW04H5.SGD","LU2506952170.USD","SG9999015986.USD","LU0964807845.USD","LU0069063385.USD","LU1035773651.USD","LU1400636657.SGD","LU2404859667.USD","GB00B4LPDJ14.GBP","TDIV","LU0310799852.SGD","LU1935043536.SGD","LU1046421795.USD","LU0466842654.USD","LU2168564495.EUR","LU0949170426.SGD","IE00BK4W5L77.USD","LU1003077747.HKD","LU0965509101.SGD","LU2462157665.USD","LU2506952097.USD","LU1121112475.USD","LU2326559502.SGD","LU1196500208.SGD","LU2125154935.USD","IE00BFXG0V08.USD","LU1506573853.SGD","SG9999015341.SGD","LU0390134368.USD","LU2047632596.USD","IE00BJJMRX11.SGD","LU0757359954.USD","LU2211815571.USD","BK4504","MSFX","LU2237957902.USD","IE0001KFT4U8.USD","LU2764262908.HKD","IE00BYXW3230.USD","LU0203202063.USD","IE0005OL40V9.USD","SG9999014898.SGD","LU2244417387.USD","LU0348723411.USD","LU0965508806.USD","LU2125909593.SGD","LU2491050154.USD","LU2360106780.USD","LU1280957306.USD","LU1983260115.SGD","LU1983299246.USD","UXI","LU2746668974.SGD","LU2237443549.SGD","LU2491049909.HKD","IBB","LU0198837287.USD","HK0000304797.USD","LU2023250504.SGD","SG9999004303.SGD","LU0097036916.USD","LU0138981039.USD","BK4554","TYLG","LU0251132253.USD","IE0009G5SDU7.USD","LU1935043452.HKD","LU2237443895.HKD","IE00BKVL7J92.USD","LU1989764748.USD","LU0820561818.USD","LU0823421416.USD","BK4581","LU0251142724.SGD","LU0820562030.AUD","LU2111349929.HKD","LU1267930573.SGD","BK4579","SG9999018865.SGD","IE00BJT1NW94.SGD","IE000MB6IJN5.SGD","LU2552382215.SGD","LU0784385840.USD","LU1244550221.USD","LU2462591277.SGD","BK4525","BK4533","VGT","IBBQ","IE00BN29S564.USD","LU0661504455.SGD","IE00BLSP4239.USD","LU2602419157.SGD","LU0742534661.SGD","NULC","TRUM","LU0545039389.USD","LU0133085943.USD","IE000YTNTUN2.SGD","LU0320765489.SGD","LU0683600562.USD","LU1037948897.HKD","LU1093756325.SGD","LU2125909247.SGD","LU0689472784.USD","LU2237443382.USD","LU1582987324.SGD","IE0000B7K699.USD","LU0690374961.EUR","LU2242649171.HKD","LU1951198990.SGD","LU2065171311.SGD","LU2041044095.USD","IE00B19Z8X17.USD","LU0289739343.SGD","SG9999014914.USD","LU1989773731.SGD","LU2750360641.GBP","LU1043141123.HKD","IE00B1XK9C88.USD","BK4567","LU0094547139.USD","LU0545562505.USD","LU1244550494.USD","LU1334329650.SGD","LU1564329032.USD","LU1066051498.USD","SGXZ80539844.SGD","LU0894486033.HKD","LU1366333091.USD","LU1868837300.USD","LU1868836591.USD","LU0006306889.USD","LU2242646821.SGD","LU2237443465.HKD","LU0143551892.USD","IE00B775H168.HKD","LU2750360997.AUD","IE00BFXG1179.USD","LU0011850046.USD","LU0238689110.USD","LU0082616367.USD","BK4576","IE00BSNM7G36.USD","LU0109392836.USD","BK4588","LU0289941410.SGD","LU2461242641.AUD","LU0289739699.SGD","LU1435385759.SGD","LU2065171402.SGD","LU0738911758.USD","LU0965509010.AUD","LU2298321311.HKD","BK4592","IE0004445239.USD","LU1989763005.USD","IE00BMPRXQ63.HKD","LU0894485498.HKD","HWAY","LU2168564065.EUR","GB00BDT5M118.USD","LU0171293334.USD","BK4577","LU1074936037.SGD","SGXZ23171101.USD","IE000F7OJYX1.SGD","LU1670628061.USD","LU2637965513.SGD","IE00BMPRXR70.SGD","LU2092937221.SGD","LU0029864427.USD","LU2097829019.USD","GASZ","LU0210528500.USD","LU0234570918.USD","LU0314106906.USD","LU2023250843.SGD","LU1852331112.SGD","LU0456855351.SGD","LU2089984988.USD","LU2106854487.HKD","LU2063271972.USD","LU2471134879.HKD","LU2360108059.USD","LU2279689827.SGD","LU0323240290.USD","LU1803068979.SGD","LU0823417653.USD","LU2552382058.USD","IE0004445015.USD","LU2065169927.USD","LU2543165471.USD","LU1670627923.USD","LU1670710661.SGD","LU0302445910.USD","LU0868494617.USD","LU2087621335.USD","LU2430703251.USD","BK4503","LU1923622614.USD","SG9999000418.SGD","LU1804176565.USD","LU1267930730.SGD","LU0289961442.SGD","IE000ITXATA3.USD","LU0823434583.USD","LU2264538146.SGD","SG9999001077.SGD","BK4550","LU0823421333.USD","LU0792757196.USD","LU0353189680.USD","RSHO","LU0784383803.USD","LU1712237335.SGD","BK4520","LU1069344957.HKD","LU0320765992.SGD","IE00BQXX3D17.EUR","LU1236620750.USD","LU0965509283.SGD","LU1935043023.USD","LU0444971666.USD","LU2271345857.HKD","LU0289960550.SGD","LU2083900584.USD","LU0342679015.USD","LU1582987597.SGD","LU0354030511.USD","IE0009355771.USD","LU1935042488.USD","LU0795875086.SGD","LU2403377893.USD","SG9999014567.USD","IE00BD6J9T35.USD","LU1674673691.USD","LU1951200564.SGD","MSFO","TRUI","LU0823417737.USD","LU2191332357.HKD","IE00BLSP4452.SGD","LU1670711040.USD","LU1221951046.USD","LU2592432038.USD","LU2860962120.EUR","LU0640476718.USD","LU0950375773.USD","IE0034235188.USD","LU2468319806.SGD","IE0003U64NQ7.SGD","LU2247934214.USD","BK4528","LU1496350502.SGD","IE00BK4W5M84.HKD","HK0000304805.HKD","IE00BFSS7M15.SGD","BK4548","LU1202635105.USD","BK4139","MSFD","LU0949170772.SGD","SG9999017495.SGD","LU0788109477.HKD","LU1267930813.SGD","LU0072461881.USD","LU0323239441.USD","LU1989764664.SGD","IE00B2B36J28.USD","LU1720051108.HKD","LU0215105999.USD","LU1400636574.HKD","LU2237443978.SGD","LU2487616109.SGD","MSFC","LU2097344357.USD","IE00BMPRXN33.USD","LU0107464264.USD","SGXZ51526630.SGD","LU1839511570.USD","IXN","LU0048584097.USD","LU0345769631.USD","LU0511384066.AUD","SG9999018857.SGD","LU1221951129.SGD","SG9999014559.SGD","LU0251131958.USD","SG9999014880.SGD","LU0234572021.USD","SG9999015952.SGD","IE00BJJMRY28.SGD","LU1232071149.USD","LU1323610961.USD","LU1880398554.USD","LU2413666699.HKD","LU1066051811.HKD","LU2381873111.SGD","LU1228905540.USD","LU2471134952.CNY","LU2100268510.USD","LU0124676726.USD","LU1814569148.SGD","SG9999014906.USD","LU1564329628.SGD","LU1721428933.USD","LU2092627202.USD","IE000W1ABFV2.USD","LU0070217475.USD","LU2505996681.GBP","LU0960925559.SGD","LU1979441026.SGD","LU0211328371.USD","IE00BHPRN162.USD","LU1496350171.SGD","LU0048573561.USD","IE00BN8TJ469.HKD","LU2237443622.USD","LU1061106388.HKD","LU0157215616.USD","LU0266013472.USD","AMGN","LU1551013342.USD","LU0889565833.HKD","FTEC","LU1629891620.HKD","LU0061474705.USD","LU1127390331.HKD","LU2505996509.AUD","LU1400636491.USD","IE00B775SV38.USD","LU0553294199.USD","LU0174119429.USD","LU0345770308.USD","LU0314104364.USD","LU2168564149.EUR","SHW","IGV","LU2347655156.SGD","IE0034235303.USD","LU0256863902.USD","ROM","LU2462591350.SGD","BK4598","LU1571399168.USD","LU0943347566.SGD","BK4543","BK4599","LU1032955483.USD","LU1235294995.USD","PBE","LU1564329461.SGD","LU0690374615.EUR","LU2089284900.SGD","LU2430703095.HKD","LU0080751232.USD","LU0724617625.USD","LU1057294990.SGD","SPTE","LU2896262040.SGD","SMSFTmain","LU2242650005.HKD","LU0957808578.USD","LU0149725797.USD","LU2087625088.SGD","LU0985320562.USD","TBXU","MSFU","LU2242652126.USD","XLK","LU0528227936.USD","BK4585","LU1119994496.HKD","LU0889566641.SGD","LU1430594728.SGD","LU1914381329.SGD","IE00BKPKM429.USD","LU1585245621.USD","LU0208291251.USD","SG9999014575.USD","IE0009356076.USD","LU2361044949.HKD","LU1023059063.AUD","IE00BFSS8Q28.SGD","CAT","LU1923623000.USD","IE00BJLML261.HKD","LU0889565916.HKD","LU2065170008.USD","LU1880398471.USD","LU2077746001.SGD","BK4534","BBH","LU1116320737.USD","BK4149","LU2491050071.SGD","IE00BDCRKT87.USD","LU2764263039.SGD","LU2023251221.USD","LU1244550577.SGD","IE00B1BXHZ80.USD","LU1974910355.USD","BK4535","LU1861127337.USD","LU2265009873.SGD","IE000KEQY171.SGD","LU0395794307.EUR","LU2756315664.SGD","LU2357305700.SGD","LU0689626769.HKD","LU2430703178.SGD","LU2471134796.USD","LU0557290698.USD","BK4597","LU1145028129.USD","OGIG","LU1429558221.USD","LU1153585028.USD","LU0225283273.USD","LU0472753341.HKD","IE000SO60NU8.SGD","LU0128525929.USD","IE00B7KXQ091.USD","LU1670756490.USD","LU0868494708.USD","LU2458330169.SGD","LU0072462426.USD","SG9999015358.SGD","LU1718418525.SGD","LU1582986433.USD","HK0000532082.HKD","LU0672654240.SGD","LU1815333072.USD","LU1084165304.USD","BK4516","LU2023250330.USD","LU0476273544.USD","LU2362541273.HKD","LU1623119135.USD","BK4566","EFIV","LU1935042215.USD","LU0787776722.HKD","LU1633808545.USD","LU2463028550.USD","LU2148611432.USD","LU0211327993.USD","LU0719512351.SGD","LU0879622024.SGD","LU1181866309.USD","LU1340139317.AUD","LU1564329115.USD","LU2452424414.USD","IE0002141913.USD","LU2133065610.SGD","IE00BJTD4V19.USD","LU1267930490.SGD","BK4097","LU1720051017.SGD","CATG","LU0354030438.USD","LU0820561909.HKD","LU1815336760.USD","IE00B4YYXB79.USD","LU0312595415.SGD","LU2237957811.SGD","LU0353189763.USD","IE00B19Z9505.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670542159","title":"US FDA Approves Mirum's Drug for Rare Bone Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2670542159","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670542159?lang=en_us&edition=fundamental","pubTime":"2026-09-26 02:57","pubTimestamp":1790362661,"startTime":"0","endTime":"0","summary":"US FDA approves Mirum's drug for rare bone disorderSept 25 (Reuters)-The US Food and Drug Administration has approved Mirum Pharmaceuticals'MIRM.Odrug to treat a rare bone disorder, the regulator said on Friday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H12T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRM","LU2362540622.SGD","TBXU","LU2106854487.HKD","LU2468319806.SGD","IBB","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","REGN","LU1974910355.USD","BK4585","BK4588","BBH","LU0882574055.USD","LU0053666078.USD","BK4550","LU2362541273.HKD","LU0109394709.USD","LU0889565916.HKD","BK4139","LU2089984988.USD","LU0823434583.USD","LU1917777945.USD","LU2362541513.USD","IBBQ","LU2237438978.USD","BK4532","LU0823434740.USD","LU2023250504.SGD","LU0114720955.EUR","IDNA","LU0823416689.USD","INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670426493","title":"Regeneron Steps Into Obesity Drug Race With New Phase 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670426493","media":"TIPRANKS","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670426493?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:31","pubTimestamp":1790353874,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals, Inc. (REGN) is running a Phase 1 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regeneron-steps-into-obesity-drug-race-with-new-phase-1-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regeneron-steps-into-obesity-drug-race-with-new-phase-1-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023250504.SGD","IBB","LU1917777945.USD","LU0889565916.HKD","LU0882574055.USD","LU2362541273.HKD","LU0114720955.EUR","LU0109394709.USD","LU2468319806.SGD","LU2089984988.USD","BBH","BK4139","LU0823434583.USD","REGN","TBXU","LU0823416689.USD","LU0823434740.USD","LU2237438978.USD","LU2362540622.SGD","LU0053666078.USD","LU0058720904.USD","IBBQ","LU1974910355.USD","BK4588","LU0320765992.SGD","LU0289739699.SGD","LU2362541513.USD","BK4585","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670642642","title":"Argenx Advances Empasiprubart Into Phase 2 for Guillain-Barré: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2670642642","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670642642?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:30","pubTimestamp":1790353846,"startTime":"0","endTime":"0","summary":"Argenx ($ARGX) announced an update on their ongoing clinical study. Argenx (ARGX) has launched a new Phase 2 study called “A Phase 2, Randomized, D...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-into-phase-2-for-guillain-barre-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-into-phase-2-for-guillain-barre-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4588","BK4139","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0109394709.USD","LU0823416689.USD","IE0034235188.USD","BK4585","LU0390134368.USD","IE00BJT1NW94.SGD","TBXU","BK4505","BK4211","LU0320765992.SGD","ARGX","IE0009355771.USD","LU0889565916.HKD","IBB","IE0002141913.USD","IE00BFTCPJ56.SGD","FMED","IE00BJJMRZ35.SGD","LU1983260115.SGD","ISBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}